ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Highlights from ESMO 2019
Prof Josep Tabernero - ESMO President
Prostate cancer updates: Advances in precision medicine and PARP inhibitors
Prof Karim Fizazi, Dr Joaquin Mateo, Dr Shahneen Sandhu and Prof Bertrand Tombal
Breast cancer highlights from ESMO 2019
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
Melanoma highlights from ESMO 2019
Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany
PARP inhibitor olaparib slows progression of advanced prostate cancer
Prof Maha Hussain - Northwestern University Feinberg School of Medicine, Chicago...
Comment: PARP inhibitors for advanced prostate cancer
Dr Ignacio Duran - Hospital Universitario Virgen del Rocío, Sevilla, Spain
Targeted therapies in prostate cancer: Recent advances presented at ESMO 2019
Dr Eleni Efstathiou, Prof Noel Clarke, Dr Elena Castro, Prof Matthew Smith
MONALEESA-3: Ribociclib plus fulvestrant in advanced breast cancer
Prof Dennis Slamon - Ronald Reagan UCLA Medical Center, Los Angeles, USA
Improvement in OS with abemaciclib plus fulvestrant in pre-, peri- and postmenop...
Prof George Sledge - Stanford Health Care, Stanford, USA
Providing quality patient care and service using the Oncology Care Model
Dr Vedner Guerrier - Memorial Healthcare System, Hollywood, FL, USA
BYLieve study results: Alpelisib and endocrine therapy in patients with PIK3CA-m...
Prof Hope Rugo - University of California, San Francisco, USA
Ribociclib plus endocrine therapy improves survival in premenopausal patients wi...
Prof Debu Tripathy - The University of Texas MD Anderson Cancer Center, Houston,...